Overview of Acic Cream
Acic Cream: A Quick Overview
| Property | Description |
|---|---|
| Active ingredient | Aciclovir (INN) 5% w/w |
| Form | Topical Cream |
| Pharmacological class | Antiviral, Synthetic Nucleoside Analog |
| Common use | Early stage treatment of cold sores (herpes labialis) |
| Availability | Often Over-the-Counter (OTC) |
What is Acic Cream and What is Its Main Ingredient?
Acic Cream is a widely recognized topical pharmaceutical preparation intended for direct application to the skin to manage viral outbreaks. Its defining active ingredient is Aciclovir (INN), a compound recognized for its selective action against herpes viruses.
This medication is a synthetic drug, meaning the Aciclovir molecule is created through chemical processes. It is formulated as a semi-solid cream at a typical concentration of 5% w/w. This specific formulation is designed for local use, allowing the active component to be concentrated at the site of the infection to interrupt the viral spread on the skin surface.
What Class of Medicine is Acic Cream and How Does it Fight Infection?
Acic Cream is classified within the pharmacological class of antivirals, specifically as a synthetic nucleoside analog. Its therapeutic purpose is rooted in its ability to selectively target and interfere with the process of viral replication, thereby limiting the growth of the pathogen.
This selective mechanism makes it a key tool in managing infections caused by the Herpes simplex virus (HSV), which is the cause of cold sores. It is intended for early intervention to decrease the duration and severity of the outbreak. Prompt application helps achieve faster relief from symptoms.
When is Acic Cream Typically Used?
Acic Cream is generally utilized for managing localized, recurrent viral infections, most notably cold sores (herpes labialis) on the lips and face. Because the cream is often available Over-the-Counter (OTC), it is primarily positioned for quick treatment upon the earliest signs of an outbreak.
The cream's function is to help alleviate associated symptoms and shorten the healing time of the visible lesions. It is generally recommended to be applied during the prodrome phase (the initial tingling or itching sensation) to maximize its effect against the active viral replication.
Regulatory References
